One after another, many of Canada’s largest cannabis greenhouses and indoor grow operations have been sold or mothballed as the industry continues to search for a supply-demand equilibrium after years of overproduction.
Some of Canada’s largest cannabis cultivators are turning to vegetables, fruits and orchids to bolster their bottom-line as macroeconomic fundamentals continue to challenge the struggling industry.
Two indices tracking the performance of cannabis businesses on North America’s largest stock exchanges have been discontinued amid waning investor interest in marijuana stocks and billions in losses suffered by the companies.
Back in the regulated marijuana industry’s more heady days, a U.S. hemp-derived CBD subsidiary seemed like the must-have accessory for any Canadian cannabis company worth its bud.
The Canadian cannabis arm of plant-based consumer packaged goods company Village Farms International experienced rising sales in the second quarter ended June 30 on strong export growth.
In the face of slumping cannabis stock prices, publicly traded Canadian marijuana producers and U.S. ancillary companies are increasingly turning to share consolidations to maintain their listings on the Nasdaq exchange.
Beleaguered cannabis producer Canopy Growth received a $0 price target by Eight Capital on Wednesday after the Toronto-based financial firm said it is no longer appropriate to value the Canadian operator as a going concern.
Marijuana industry cultivation and extraction solutions company Agrify Corp. consolidated its shares on a 20-to-1 basis in order to maintain its equity listing on the Nasdaq stock exchange.
Canadian cannabis producer Hexo reported a total net loss before tax of 129.7 million Canadian dollars ($98 million) in the company’s third quarter, bringing accumulated losses since 2016 to more than CA$2 billion.
European cannabis executives would welcome a decision by the German government to pursue a trial recreational cannabis program versus nationwide legalization – even if that meant a significantly smaller market for businesses to pursue.
The German government might be having second thoughts about its plans to pursue full-fledged adult-use cannabis legalization in Europe’s largest economy.
Aurora Cannabis CEO Miguel Martin discusses his role in the “transformation” of the company from a money-losing venture to one on the upswing.
